This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/chebi/
n14http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/kegg-compound/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/pubchem-compound/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04075/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04075
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n14:DB04075 n15:DB04075
dcterms:title
N-Acetyl-L-Glutamate
adms:identifier
n7:70914 n8:46507366 n9:C00624 n10:NLG n11:17533 n12:DB04075
n3:IUPAC-Name
n4:271B5ECD-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5ED3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5ED2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5ECF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5ED0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5ED1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5ECB-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5EC9-363D-11E5-9242-09173F13E4C5 n4:271B5ECC-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5ECA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5ED9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5EDA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5ED4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5ED5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5ED7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5ED6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5ED8-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1188-37-0
n3:Bioavailability
n4:271B5EDF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5EE1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5EE2-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5EE3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5EDE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5EDD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5EE0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5ECE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5EDB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5EDC-363D-11E5-9242-09173F13E4C5